思宇年度活动回顾： 首届全球眼科大会 | 首届全球骨科大会 | 首届全球心血管大会 即将召开： 2025年7月17日，第二届全球医疗科技大会 2025年9月4-5日，第三届全球手术机器人大会 2025年6月10日， 美敦力（Medtronic ）宣布任命 凯特·本尼迪克特（Kate Benedict） 为急性护理和监测 （Acute Care & Monitoring, ACM）部门的高级副总裁（SVP）兼总裁，同时她将加入美敦力医疗外科产品 组合（Medical Surgical Portfolio）的领导团队。 # 关于 凯特·本尼迪克特 凯特·本尼迪克特 拥有超过25年的医疗行业经验，涵盖医疗器械、诊断、制药和药物传递等领域，以推动创 新、实现超市场增长和优化运营效率而著称。以下是她的职业履历： 特拉华大学（University of Delaware）：会计学理学士（BS）。 美敦力医疗外科产品组合执行副总裁兼总裁 Mike Marinaro 评价本尼迪克特为"激励人心且具有战略眼光的领 导者"，她的"以人为本、以患者为中心"的领导风格和深厚的行业经验使其非常适合领导ACM部门。 本尼迪克特 表示：" ...

Core Viewpoint - Medtronic has appointed Kate Benedict as the Senior Vice President and President of the Acute Care & Monitoring (ACM) division, marking a strategic shift in response to market changes and aiming for growth in the healthcare sector [6][15]. Summary by Sections Appointment of Kate Benedict - Kate Benedict brings over 25 years of experience in the medical industry, with a focus on medical devices, diagnostics, pharmaceuticals, and drug delivery [4]. - She has held leadership roles at Flex, BD, Alcon, and Johnson & Johnson, demonstrating a strong background in driving innovation and market growth [5]. Recent Changes at Medtronic - Medtronic has undergone significant personnel changes, including the departure of key executives and the restructuring of its ACM division [7][8]. - The company decided to integrate its patient monitoring and respiratory intervention businesses into the new ACM division instead of divesting them, which had previously been valued at $9 billion [8][11]. Market Dynamics and Strategic Focus - The ACM market has seen substantial changes, particularly due to the decline in demand for ventilators post-COVID-19, prompting Medtronic to focus on high-growth monitoring technologies [11]. - The ACM division's product line includes pulse oximeters, remote patient monitoring, airway management, and respiratory monitoring products, aimed at meeting new market demands [11][13]. Financial Outlook - Medtronic's revenue for fiscal year 2024 was $32.4 billion, with the medical surgical portfolio, including ACM, accounting for approximately 26% of this revenue [11]. - The ACM division is positioned within a $100 billion market potential, particularly in chronic disease management and post-operative care, seen as a growth engine for the company [11]. Recent Developments - In April 2025, Medtronic entered a distribution agreement with Retia Medical to introduce the Argos™ cardiac output monitor, enhancing its monitoring capabilities in the ACM field [14].